Dermatology
The Case for Change in Chronic Hand Eczema
Chronic hand eczema (CHE) is a serious, often overlooked disease that significantly affects quality of life, work, and mental well-being. The White Paper calls for earlier recognition, improved diagnosis, more patient-centred care, and broader access to newer targeted treatments to improve outcomes.
Steering Committee
Prof. Sonja Molin (Charité Berlin, Germany), dermatologist
Prof. Swen Malte John (Osnabrück University, Germany), dermatologist
Prof. Peter van de Kerkhof (Radboudumc, the Netherlands), dermatologist
Dr Tina Mesarič (Atopika Institute, Slovenia), patient representative
Dermatology
Proposal for the Addition of Adalimumab to the World Health Organization Model List of Essential Medicines for the Treatment of Adults and Children with Severe Psoriasis
This submission advocates for the inclusion of adalimumab on the World Health Organisation (WHO) Essential Medicines List (EML) and EMLc listings as critical therapies for the treatment of moderate-to-severe psoriasis. The proposal is an individual entry and a representative of its pharmacological class: tumour necrosis factor (TNF) inhibitors.
Dermatology
Proposal for the Addition of Ustekinumab to the World Health Organization Model List of Essential Medicines for the Treatment of Adults and Children with Severe Psoriasis
This application is for the addition of a new drug, ustekinumab, to the World Health Organization (WHO) Essential Medicines List (EML) and EMLc as a critical therapy for the treatment of moderate-to-severe psoriasis. The proposal is an individual entry and a representative of its pharmacological class: interleukin (IL)-12 and IL-23.